Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proton Pump Inhibitors | 7 | 2024 | 551 | 1.910 |
Why?
|
Colorectal Neoplasms | 19 | 2023 | 6853 | 1.420 |
Why?
|
Hepatitis B, Chronic | 8 | 2019 | 403 | 1.250 |
Why?
|
Colonic Polyps | 4 | 2021 | 551 | 0.910 |
Why?
|
Feces | 7 | 2024 | 1455 | 0.900 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2016 | 301 | 0.890 |
Why?
|
Adenomatous Polyps | 2 | 2021 | 108 | 0.880 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 138 | 0.810 |
Why?
|
Sulfur Compounds | 1 | 2021 | 33 | 0.770 |
Why?
|
Diverticulitis | 5 | 2024 | 182 | 0.750 |
Why?
|
Bacteria | 3 | 2021 | 2199 | 0.690 |
Why?
|
Diet | 14 | 2024 | 8010 | 0.670 |
Why?
|
Health Occupations | 1 | 2020 | 222 | 0.650 |
Why?
|
Adenoma | 7 | 2020 | 2148 | 0.630 |
Why?
|
Anti-Bacterial Agents | 9 | 2023 | 7408 | 0.620 |
Why?
|
Hepatitis B virus | 6 | 2016 | 522 | 0.590 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.580 |
Why?
|
Cultural Diversity | 1 | 2020 | 365 | 0.550 |
Why?
|
Hepatitis B | 2 | 2013 | 701 | 0.550 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2023 | 2421 | 0.540 |
Why?
|
Sulfur | 3 | 2021 | 163 | 0.540 |
Why?
|
Vaccination | 3 | 2022 | 3361 | 0.500 |
Why?
|
Alanine Transaminase | 3 | 2015 | 606 | 0.490 |
Why?
|
Prospective Studies | 40 | 2024 | 54303 | 0.470 |
Why?
|
Precancerous Conditions | 1 | 2021 | 977 | 0.470 |
Why?
|
Self Report | 9 | 2022 | 3711 | 0.430 |
Why?
|
Metagenome | 5 | 2024 | 450 | 0.430 |
Why?
|
Metagenomics | 6 | 2024 | 457 | 0.430 |
Why?
|
Irritable Bowel Syndrome | 3 | 2023 | 453 | 0.420 |
Why?
|
Feeding Behavior | 4 | 2021 | 3185 | 0.410 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3085 | 0.410 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3205 | 0.410 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2021 | 2299 | 0.400 |
Why?
|
Sulfur-Reducing Bacteria | 2 | 2021 | 15 | 0.390 |
Why?
|
Health Personnel | 5 | 2021 | 3310 | 0.390 |
Why?
|
Hepatitis C, Chronic | 3 | 2019 | 1031 | 0.380 |
Why?
|
Incidence | 17 | 2022 | 21392 | 0.380 |
Why?
|
Biomedical Research | 2 | 2021 | 3426 | 0.370 |
Why?
|
Middle Aged | 63 | 2024 | 220352 | 0.360 |
Why?
|
Liver Cirrhosis | 4 | 2017 | 1931 | 0.340 |
Why?
|
Life Style | 2 | 2021 | 3896 | 0.340 |
Why?
|
United States | 30 | 2024 | 72461 | 0.330 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1190 | 0.330 |
Why?
|
Risk Factors | 32 | 2023 | 74359 | 0.320 |
Why?
|
Adult | 57 | 2024 | 219994 | 0.320 |
Why?
|
Humans | 106 | 2024 | 760621 | 0.320 |
Why?
|
Dietary Fiber | 3 | 2024 | 760 | 0.310 |
Why?
|
Sweden | 5 | 2023 | 1381 | 0.290 |
Why?
|
Pandemics | 10 | 2022 | 8624 | 0.280 |
Why?
|
Liver Neoplasms | 6 | 2021 | 4319 | 0.280 |
Why?
|
Blastocystis | 2 | 2024 | 21 | 0.280 |
Why?
|
Female | 67 | 2024 | 391270 | 0.270 |
Why?
|
Aged | 44 | 2024 | 169152 | 0.270 |
Why?
|
Follow-Up Studies | 19 | 2023 | 39261 | 0.260 |
Why?
|
Cesarean Section | 2 | 2023 | 1385 | 0.260 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1348 | 0.260 |
Why?
|
Male | 59 | 2024 | 359744 | 0.250 |
Why?
|
Age of Onset | 3 | 2021 | 3301 | 0.250 |
Why?
|
Hepacivirus | 2 | 2011 | 1334 | 0.240 |
Why?
|
Risk Assessment | 9 | 2021 | 24123 | 0.230 |
Why?
|
Brain Ischemia | 1 | 2017 | 3127 | 0.230 |
Why?
|
Case-Control Studies | 10 | 2024 | 22053 | 0.230 |
Why?
|
Time Factors | 10 | 2024 | 40165 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8515 | 0.220 |
Why?
|
Cohort Studies | 13 | 2024 | 41335 | 0.210 |
Why?
|
Antiviral Agents | 5 | 2015 | 3061 | 0.210 |
Why?
|
Multivariate Analysis | 8 | 2021 | 12159 | 0.200 |
Why?
|
Postprandial Period | 2 | 2021 | 315 | 0.200 |
Why?
|
Propionates | 1 | 2023 | 182 | 0.200 |
Why?
|
Vitamin D-Binding Protein | 1 | 2023 | 131 | 0.200 |
Why?
|
Diet Surveys | 3 | 2021 | 1161 | 0.200 |
Why?
|
Butyrates | 1 | 2023 | 169 | 0.200 |
Why?
|
Dementia | 1 | 2016 | 2649 | 0.200 |
Why?
|
Ageusia | 1 | 2021 | 19 | 0.190 |
Why?
|
Proportional Hazards Models | 8 | 2021 | 12531 | 0.190 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 2125 | 0.190 |
Why?
|
Health Surveys | 3 | 2021 | 4063 | 0.190 |
Why?
|
Hepatitis C | 1 | 2011 | 1579 | 0.180 |
Why?
|
Public Health | 3 | 2021 | 2653 | 0.180 |
Why?
|
Data Collection | 2 | 2020 | 3315 | 0.180 |
Why?
|
Adenoma, Villous | 1 | 2020 | 14 | 0.180 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 102 | 0.180 |
Why?
|
Cough | 2 | 2021 | 595 | 0.180 |
Why?
|
Obesity | 6 | 2024 | 12922 | 0.180 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 141 | 0.180 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.170 |
Why?
|
Colonoscopy | 5 | 2021 | 1387 | 0.170 |
Why?
|
Defecation | 1 | 2021 | 190 | 0.170 |
Why?
|
Hepatitis B e Antigens | 3 | 2015 | 133 | 0.160 |
Why?
|
Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
Dyspnea | 3 | 2021 | 1352 | 0.160 |
Why?
|
Masks | 1 | 2021 | 209 | 0.160 |
Why?
|
Tooth Loss | 1 | 2020 | 198 | 0.160 |
Why?
|
Career Mobility | 1 | 2020 | 258 | 0.150 |
Why?
|
Age Factors | 7 | 2021 | 18416 | 0.150 |
Why?
|
Rifamycins | 1 | 2017 | 26 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 402 | 0.150 |
Why?
|
Young Adult | 15 | 2023 | 58741 | 0.150 |
Why?
|
Biodiversity | 1 | 2020 | 345 | 0.150 |
Why?
|
Fruit | 2 | 2021 | 1160 | 0.150 |
Why?
|
Vegetables | 2 | 2021 | 1196 | 0.150 |
Why?
|
Diet, Mediterranean | 2 | 2021 | 735 | 0.140 |
Why?
|
Progestins | 1 | 2019 | 302 | 0.140 |
Why?
|
Fever | 2 | 2021 | 1617 | 0.140 |
Why?
|
Nurses | 4 | 2021 | 2467 | 0.140 |
Why?
|
Periodontal Diseases | 1 | 2020 | 452 | 0.140 |
Why?
|
DNA, Viral | 4 | 2016 | 2194 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 80 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 707 | 0.130 |
Why?
|
Television | 1 | 2019 | 409 | 0.130 |
Why?
|
Siblings | 1 | 2020 | 824 | 0.130 |
Why?
|
Social Justice | 1 | 2020 | 479 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 707 | 0.130 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 380 | 0.130 |
Why?
|
Microsatellite Instability | 1 | 2019 | 715 | 0.130 |
Why?
|
Communicable Disease Control | 1 | 2022 | 844 | 0.130 |
Why?
|
Stroke | 1 | 2017 | 9962 | 0.120 |
Why?
|
Peritonitis | 1 | 2017 | 369 | 0.120 |
Why?
|
Weight Gain | 3 | 2023 | 2347 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 742 | 0.120 |
Why?
|
Inflammation | 4 | 2023 | 10756 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2022 | 58995 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1201 | 0.120 |
Why?
|
Health Status | 3 | 2021 | 4081 | 0.110 |
Why?
|
Population Surveillance | 2 | 2021 | 2608 | 0.110 |
Why?
|
Adolescent | 12 | 2022 | 87810 | 0.110 |
Why?
|
Gastroesophageal Reflux | 1 | 2021 | 816 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1433 | 0.110 |
Why?
|
Energy Intake | 1 | 2021 | 2129 | 0.110 |
Why?
|
Depression | 2 | 2023 | 8044 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1399 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 700 | 0.100 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7806 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1379 | 0.100 |
Why?
|
Cognition | 2 | 2022 | 6957 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1206 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1152 | 0.100 |
Why?
|
Comorbidity | 3 | 2018 | 10551 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12293 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1520 | 0.100 |
Why?
|
Liver Transplantation | 2 | 2014 | 2325 | 0.100 |
Why?
|
Liver Failure | 1 | 2014 | 249 | 0.100 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1291 | 0.100 |
Why?
|
Biopsy | 2 | 2020 | 6771 | 0.100 |
Why?
|
Overweight | 1 | 2022 | 2421 | 0.090 |
Why?
|
Prebiotics | 1 | 2021 | 41 | 0.090 |
Why?
|
Mental Health | 2 | 2022 | 3213 | 0.090 |
Why?
|
Prevotella | 2 | 2021 | 80 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9467 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3202 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7593 | 0.090 |
Why?
|
Blood Glucose | 2 | 2021 | 6381 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3505 | 0.080 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 353 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1403 | 0.080 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25942 | 0.080 |
Why?
|
Sex Factors | 6 | 2021 | 10547 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1919 | 0.080 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2009 | 224 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2275 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15289 | 0.080 |
Why?
|
Carcinoma | 1 | 2020 | 2331 | 0.080 |
Why?
|
Viremia | 1 | 2011 | 707 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2526 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3616 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15840 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3763 | 0.070 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 167 | 0.070 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15757 | 0.070 |
Why?
|
Constipation | 2 | 2023 | 561 | 0.070 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 998 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2013 | 2362 | 0.070 |
Why?
|
Probiotics | 1 | 2021 | 377 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3959 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8803 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4538 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12626 | 0.070 |
Why?
|
Fungi | 1 | 2019 | 339 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2010 | 918 | 0.070 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2009 | 491 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2020 | 1006 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3758 | 0.070 |
Why?
|
Health | 1 | 2019 | 396 | 0.070 |
Why?
|
Software | 1 | 2020 | 4419 | 0.070 |
Why?
|
Prognosis | 4 | 2021 | 29658 | 0.070 |
Why?
|
Cause of Death | 3 | 2022 | 3725 | 0.060 |
Why?
|
Mutation | 3 | 2019 | 29932 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4373 | 0.060 |
Why?
|
Viruses | 1 | 2019 | 376 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7588 | 0.060 |
Why?
|
Species Specificity | 1 | 2019 | 2418 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 1189 | 0.060 |
Why?
|
Bilophila | 1 | 2024 | 12 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15687 | 0.060 |
Why?
|
Blastocystis Infections | 1 | 2024 | 17 | 0.060 |
Why?
|
Barrett Esophagus | 1 | 2008 | 490 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3334 | 0.060 |
Why?
|
Vitamins | 2 | 2023 | 1634 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1791 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2017 | 3976 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2022 | 80372 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13502 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 100 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 136 | 0.050 |
Why?
|
Safety | 2 | 2021 | 1148 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 382 | 0.050 |
Why?
|
Phylogeny | 1 | 2019 | 2775 | 0.050 |
Why?
|
Fusobacterium | 1 | 2021 | 54 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5799 | 0.050 |
Why?
|
Odds Ratio | 3 | 2021 | 9716 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5785 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2021 | 98 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 83 | 0.050 |
Why?
|
California | 3 | 2010 | 1416 | 0.050 |
Why?
|
Sigmoidoscopy | 1 | 2021 | 150 | 0.050 |
Why?
|
Food Microbiology | 1 | 2021 | 76 | 0.050 |
Why?
|
Body Weight | 2 | 2023 | 4611 | 0.040 |
Why?
|
Fast Foods | 1 | 2022 | 210 | 0.040 |
Why?
|
Taste Disorders | 1 | 2020 | 38 | 0.040 |
Why?
|
England | 1 | 2020 | 526 | 0.040 |
Why?
|
Hunger | 1 | 2021 | 206 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2021 | 296 | 0.040 |
Why?
|
Israel | 1 | 2021 | 722 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2023 | 789 | 0.040 |
Why?
|
Vitamin D | 2 | 2023 | 3291 | 0.040 |
Why?
|
Mass Screening | 3 | 2022 | 5423 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 470 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1697 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3388 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11847 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 400 | 0.040 |
Why?
|
Body Mass Index | 3 | 2022 | 12914 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 670 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 224 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13630 | 0.040 |
Why?
|
Metabolome | 1 | 2024 | 982 | 0.040 |
Why?
|
Pregnancy | 2 | 2023 | 29749 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2022 | 7021 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1242 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 516 | 0.030 |
Why?
|
Hyperplasia | 1 | 2020 | 1155 | 0.030 |
Why?
|
Diarrhea | 1 | 2023 | 1319 | 0.030 |
Why?
|
Exercise | 2 | 2023 | 5787 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1180 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3441 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2023 | 932 | 0.030 |
Why?
|
Ascites | 1 | 2017 | 338 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 558 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 65017 | 0.030 |
Why?
|
Intestines | 1 | 2024 | 1907 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1131 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 486 | 0.030 |
Why?
|
Obesity, Abdominal | 1 | 2018 | 374 | 0.030 |
Why?
|
Metabolomics | 1 | 2024 | 1628 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 692 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1603 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 822 | 0.030 |
Why?
|
Waist Circumference | 1 | 2018 | 926 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1106 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14660 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2005 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1544 | 0.030 |
Why?
|
Viral Load | 2 | 2012 | 3322 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1881 | 0.030 |
Why?
|
Genotype | 3 | 2012 | 12960 | 0.030 |
Why?
|
Hemodynamics | 1 | 2022 | 4174 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1928 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1725 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22072 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1548 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1902 | 0.020 |
Why?
|
Risk | 1 | 2023 | 9631 | 0.020 |
Why?
|
Texas | 1 | 2010 | 401 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6360 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3839 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4899 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1878 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4351 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42063 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3364 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1530 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2916 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6218 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3562 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2179 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5877 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10827 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3844 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2387 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9287 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12808 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2008 | 351 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16546 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14495 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5397 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15789 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2629 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8469 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9411 | 0.010 |
Why?
|
Child | 2 | 2021 | 79806 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10182 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6538 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36060 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.010 |
Why?
|
Animals | 1 | 2019 | 167963 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13981 | 0.010 |
Why?
|
Concepts
(308)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_